Trinity Biotech (TRIB) Long-Term Investments (2017 - 2025)
Trinity Biotech's Long-Term Investments history spans 8 years, with the latest figure at $249000.0 for Q4 2025.
- On a quarterly basis, Long-Term Investments fell 89.86% to $249000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $249000.0, a 89.86% decrease, with the full-year FY2025 number at $249000.0, down 89.86% from a year prior.
- Long-Term Investments hit $249000.0 in Q4 2025 for Trinity Biotech, down from $2.8 million in the prior quarter.
- Over the last five years, Long-Term Investments for TRIB hit a ceiling of $21.8 million in Q4 2021 and a floor of $128000.0 in Q4 2022.
- Historically, Long-Term Investments has averaged $5.4 million across 5 years, with a median of $2.6 million in 2024.
- Biggest five-year swings in Long-Term Investments: tumbled 99.41% in 2022 and later surged 3723.44% in 2023.
- Tracing TRIB's Long-Term Investments over 5 years: stood at $21.8 million in 2021, then tumbled by 99.41% to $128000.0 in 2022, then surged by 3723.44% to $4.9 million in 2023, then crashed by 49.84% to $2.5 million in 2024, then plummeted by 89.86% to $249000.0 in 2025.
- Business Quant data shows Long-Term Investments for TRIB at $249000.0 in Q4 2025, $2.8 million in Q2 2025, and $2.5 million in Q4 2024.